Jazz Pharmaceuticals, Inc.

NASDAQ: JAZZ
$178.16
+$2.26 (+1.3%)
Closing price May 13, 2021
Stocks were indicated up strong by almost 1% on Wednesday morning for the Dow Jones industrial average, S&P 500 and Nasdaq, quite similar to Tuesday’s gap-up open. This follows last...
24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest of 2018.
The top analyst upgrades, downgrades and other research calls from Wednesday include AECOM, CyberArk, Dillard's, Hasbro, Mattel, Newell, Papa John's, Shopify, Snap and Tesla.
The top analyst upgrades, downgrades and other research calls from Wednesday include AT&T, Comcast, Hess, Netflix, Petrobras, Sirius XM, Texas Instruments, Verizon and Walt Disney.
There is deep value for long-term investors in these specialty pharmaceutical companies, and the ability to buy in to some of the best companies in the industry at rock bottom pricing.
Monday’s top analyst upgrades, downgrades and initiations include AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical and Unilever.
24/7 Wall St. screened the Stifel specialty pharmaceutical list and found five stock rated Buy that have massive upside potential and probably don’t have the investment risk of some of the more...
There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be one.
One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be “deep value” plays at Merrill Lynch.
ImmunoGen announced this week that it has decided to partner with Jazz Pharmaceuticals, and investors have pushed Immunogen shares to a new 52-week high.
ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Cerner, Cisco Systems, Johnson & Johnson, Level 3 Communications and Salesforce.com.
The top analyst upgrades, downgrades and initiations seen on Thursday include AMD, Panera, SeaWorld, T-Mobile, Walgreens and 8Point3.
Trump said last week that companies in the health care sector are “getting away with murder,” and that something had to change. The sector has pulled back slightly since then, but there are still...
All three of these specialty pharmaceutical stocks come with a fair share of risk but provide big upside potential as well.